ALLHAT Supports First-Line Norvasc Use, Pfizer Claims
Pfizer plans to use the ALLHAT clinical study results to promote the calcium channel blocker Norvasc (amlodipine) in 2003
Pfizer plans to use the ALLHAT clinical study results to promote the calcium channel blocker Norvasc (amlodipine) in 2003